ATE417834T1 - N-oxide als prodrugs von piperazin- und piperidinderivaten - Google Patents
N-oxide als prodrugs von piperazin- und piperidinderivatenInfo
- Publication number
- ATE417834T1 ATE417834T1 AT06778284T AT06778284T ATE417834T1 AT E417834 T1 ATE417834 T1 AT E417834T1 AT 06778284 T AT06778284 T AT 06778284T AT 06778284 T AT06778284 T AT 06778284T AT E417834 T1 ATE417834 T1 AT E417834T1
- Authority
- AT
- Austria
- Prior art keywords
- art
- relates
- disease
- manufacture
- disclosed
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title abstract 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000011688 Generalised anxiety disease Diseases 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000020114 Schizophrenia and other psychotic disease Diseases 0.000 abstract 1
- 208000012886 Vertigo Diseases 0.000 abstract 1
- 230000016571 aggressive behavior Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 235000019788 craving Nutrition 0.000 abstract 1
- 208000029364 generalized anxiety disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 231100000889 vertigo Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70982105P | 2005-08-22 | 2005-08-22 | |
| EP05107671 | 2005-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE417834T1 true ATE417834T1 (de) | 2009-01-15 |
Family
ID=39246895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06778284T ATE417834T1 (de) | 2005-08-22 | 2006-08-21 | N-oxide als prodrugs von piperazin- und piperidinderivaten |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1919883B1 (de) |
| JP (1) | JP2009504799A (de) |
| KR (1) | KR20080046205A (de) |
| AT (1) | ATE417834T1 (de) |
| AU (1) | AU2006283882B2 (de) |
| CA (1) | CA2621158A1 (de) |
| DE (1) | DE602006004363D1 (de) |
| DK (1) | DK1919883T3 (de) |
| ES (1) | ES2318783T3 (de) |
| HR (1) | HRP20090143T3 (de) |
| IL (1) | IL188903A0 (de) |
| NO (1) | NO20081435L (de) |
| PL (1) | PL1919883T3 (de) |
| PT (1) | PT1919883E (de) |
| RU (1) | RU2394821C2 (de) |
| SI (1) | SI1919883T1 (de) |
| WO (1) | WO2007023141A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7964604B2 (en) | 2005-02-18 | 2011-06-21 | Solvay Pharmaceuticals B.V. | Bifeprunox mesylate maintenance dose compositions and methods for using the same |
| US7423040B2 (en) | 2005-02-18 | 2008-09-09 | Irene Eijgendaal | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
| US7786126B2 (en) | 2006-06-16 | 2010-08-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising SLV308 and a dopamine agonist |
| CA2654719A1 (en) * | 2006-06-16 | 2007-12-21 | Solvay Pharmaceuticals B.V. | Combination preparations comprising slv308 and a l-dopa |
| AU2007291234A1 (en) | 2006-08-31 | 2008-03-06 | Solvay Pharmaceuticals B.V. | Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
| CN101711236B (zh) * | 2007-04-12 | 2012-10-31 | Nsab神经研究瑞典公司分公司 | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 |
| EP2234990A1 (de) * | 2008-01-15 | 2010-10-06 | Abbott Healthcare Products B.V. | Bifeprunox-derivate |
| WO2011023796A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Healthcare Products B.V. | Bifeprunox for treating addiction |
| MX347209B (es) | 2011-12-08 | 2017-04-19 | Teva Pharmaceuticals Int Gmbh | La sal de bromhidrato de pridopidina. |
| AU2013243461A1 (en) | 2012-04-04 | 2014-11-06 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE503170A (de) * | 1975-09-02 | |||
| AU708053B2 (en) * | 1996-03-29 | 1999-07-29 | Duphar International Research B.V. | Piperazine and piperidine compounds |
| UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
| US6911448B2 (en) * | 2000-05-12 | 2005-06-28 | Solvay Pharmaceuticals B.V. | Piperazine and piperidine compounds |
| RU2301806C2 (ru) * | 2002-01-16 | 2007-06-27 | Янссен Фармацевтика Н.В. | Прукалоприд-n-оксид |
-
2006
- 2006-08-21 AT AT06778284T patent/ATE417834T1/de active
- 2006-08-21 DK DK06778284T patent/DK1919883T3/da active
- 2006-08-21 JP JP2008527453A patent/JP2009504799A/ja active Pending
- 2006-08-21 RU RU2008110945/04A patent/RU2394821C2/ru not_active IP Right Cessation
- 2006-08-21 KR KR1020087006996A patent/KR20080046205A/ko not_active Ceased
- 2006-08-21 PL PL06778284T patent/PL1919883T3/pl unknown
- 2006-08-21 WO PCT/EP2006/065477 patent/WO2007023141A1/en not_active Ceased
- 2006-08-21 SI SI200630214T patent/SI1919883T1/sl unknown
- 2006-08-21 PT PT06778284T patent/PT1919883E/pt unknown
- 2006-08-21 CA CA002621158A patent/CA2621158A1/en not_active Abandoned
- 2006-08-21 HR HR20090143T patent/HRP20090143T3/xx unknown
- 2006-08-21 DE DE602006004363T patent/DE602006004363D1/de active Active
- 2006-08-21 AU AU2006283882A patent/AU2006283882B2/en not_active Ceased
- 2006-08-21 ES ES06778284T patent/ES2318783T3/es active Active
- 2006-08-21 EP EP06778284A patent/EP1919883B1/de not_active Not-in-force
-
2008
- 2008-01-21 IL IL188903A patent/IL188903A0/en unknown
- 2008-03-19 NO NO20081435A patent/NO20081435L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT1919883E (pt) | 2009-03-26 |
| EP1919883B1 (de) | 2008-12-17 |
| HRP20090143T3 (hr) | 2009-04-30 |
| WO2007023141A1 (en) | 2007-03-01 |
| DK1919883T3 (da) | 2009-04-14 |
| RU2394821C2 (ru) | 2010-07-20 |
| IL188903A0 (en) | 2008-04-13 |
| DE602006004363D1 (de) | 2009-01-29 |
| ES2318783T3 (es) | 2009-05-01 |
| AU2006283882A1 (en) | 2007-03-01 |
| JP2009504799A (ja) | 2009-02-05 |
| EP1919883A1 (de) | 2008-05-14 |
| RU2008110945A (ru) | 2009-09-27 |
| PL1919883T3 (pl) | 2009-06-30 |
| AU2006283882B2 (en) | 2011-06-23 |
| CA2621158A1 (en) | 2007-03-01 |
| SI1919883T1 (sl) | 2009-04-30 |
| KR20080046205A (ko) | 2008-05-26 |
| NO20081435L (no) | 2008-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081435L (no) | N-oksider som prodroger for piperazin- og piperidinderivater | |
| ATE493407T1 (de) | 3-(heteroaryloxy)-2-alkyl-1- azabicycloalkylderivate als alpha.7-nachr- liganden zur behandlung von zns-erkrankungen | |
| TW200505907A (en) | Piperidine-benzenesulfonamide derivatives | |
| NO20060768L (no) | 1-(2-amino-benzol)-piperazinderivater som glycinopptaks-inhibitorer for behandling av psykoser | |
| ATE358482T1 (de) | 1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten | |
| BRPI0507984B8 (pt) | composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamífero, para melhorar a resistência de insulina em um mamífero e para prevenir ou tratar doenças circulatórias em um mamífero, e, uso do composto | |
| NO20071719L (no) | Pyridylinhibitorer for "hedgehog"-signalisering | |
| ES2162257T3 (es) | N-aminoalquildibenzofurancarboxamidas como ligandos especificos del subtipo de receptor de la dopamina. | |
| UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| EP1921077A4 (de) | Mittel zur behandlung und/oder prävention von schlafstörungen | |
| BRPI0606740A2 (pt) | compostos de bis arila e heteroarila substituìdas como antagonistas de 5ht2a seletivos | |
| NO20083349L (no) | Anvendelse av 2-imidazoler for behandling av CNS sykdommer | |
| ATE201676T1 (de) | N-azacycloalkylalkyldibenzothiophencarboxamide: spezifische liganden für dopaminrezeptorsubtypen | |
| MX2009010727A (es) | Heterociclos como antagonistas de orexina. | |
| NO20072972L (no) | Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler | |
| GB0412314D0 (en) | Compounds | |
| DE60200135D1 (de) | 4-(2-Pyridyl)piperazine als Agonisten des 5HT7 Rezeptors | |
| CO5640133A2 (es) | Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de la serotonina | |
| TW200738656A (en) | N-oxides as prodrugs of piperazine and piperidine derivatives | |
| UA96756C2 (en) | N-oxides of pyridylmethylpiperazine and -piperidine derivatives | |
| ATE334980T1 (de) | Verfahren zur herstellung von 2-methyl piperazine derivaten. | |
| BRPI0410613A (pt) | preparação de quinoxalinas substituìdas a partir da dianlina com 2,3-diidróxi-1,4-dioxano | |
| DE69906728D1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen | |
| RU2005130647A (ru) | НОВЫЕ ПРОИЗВОДНЫЕ АМИНОПИРИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGIuR5 | |
| IL188109A0 (en) | Chloro-substituted guanidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1919883 Country of ref document: EP |